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Introduction
One of the skills every researcher must learn is how to present 
complex ideas and medical or scientific terms to a “lay” 
audience. That audience includes carers, long-term users of 
services, organisations representing consumers’ interests, 
members of the public who are the potential recipients of 
health promotion programmes, or researchers from a different 
clinical or academic background to their own.
1.  What is a lay summary?
The most succinct definition the authors have found is by 
Buckland et al (2007), part of the National Institute for Health 
Research funded INVOLVE programme to encourage “People 
in Research” who define a lay summary as
“a brief summary of a research project or a research 
proposal that has been written for members of the public, 
rather than researchers or professionals. It should be 
written in plain English, avoid the use of jargon and 
explain any technical terms that have to be included” [1]
2. The three purposes of a lay summary
The lay summary is used by grant funders as part of 
• Grant application and ethical review processes
• Public understanding of science, particularly important
for fundraising charities
• Raising and justifying funds from government for 
science to underpin improvements in healthcare.
3.  What should a lay summary contain?
To fulfil these purposes, the lay summary should: 
 Paint the big picture
The lay summary is probably the first, maybe the only part of a 
grant application that a busy reviewer will actually read, so it 
needs to give an overview of the whole project – its 
background, aims and expected impact. 
For example: The Cystic Fibrosis (CF) Trust is typical of a UK charity 
that has both parent and patient representatives sitting on its Research 
Advisory Committee alongside science and medical experts.  Their input 
and opinions are seen as very important by the CF Trust, and the lay 
summary will also be read by the charity’s Trustees when giving their 
approval to the applications that have been recommended to them for 
funding.
 Be written in “plain English”
But how plain?  While it may be obvious not to use medical 
jargon, to spell out abbreviations and try to explain technical 
terms, “plain English” means different things to different 
people.  The guidance offered by funders is often contradictory 
and frequently unclear. 
For example: The Medical Research Council (MRC) advises that the lay 
summary should be written “for a reader of a middle-market tabloid 
newspaper.” - probably not a style that comes naturally to most 
researchers even if they regularly read the Daily Mail or the Daily 
Express.   The Biotechnology & Biological Sciences Research Council 
(BBSRC) simply says write “in a way that could be publicised to a 
general audience”.   Perhaps most challenging, the Engineering & 
Physical Sciences Research Council (EPSRC), which funds extensive 
medical engineering research, has said the lay summary should suit “an 
interested 14 year old”.   That is, a child with some scientific knowledge 
but below the level of GCSE sciences. 
Charities’ guidance confuses the picture even further.  The Prostate 
Cancer Charity says the lay summary “should be pithy and jargon free 
as far as possible”.   Arthritis Research UK asks that “The lay summary 
should be written as if it were to be published in the science pages of a 
major broadsheet paper or a journal such as The Economist. Bill 
Bryson‟s book, „A short history of nearly everything‟, is a stunning 
example of how everyday objects and activities can be used to 
describe complex areas of science including nuclear physics and 
astronomy.”    ARUK goes on to suggest the writer should consider
“using simple analogies to give the reader the sense, if not the detail, 
of what you are planning to do” [3].
Most researchers, and 
those who support them, 
find writing a lay 
summary a difficult task. 
This poster explores 
some of the purposes 
and current tensions 
surrounding its use.
Conclusion
The role of the lay summary is changing, and for many grant 
funders it is clearly becoming more important: for example  
Arthritis Research UK is now putting projects to a lay audience 
for assessment before scientific peer review.  Funders differ in 
what they expect from it, and there is no consensus on guiding 
applicants how to write one.  Could the Research Councils or 
Association of Medical Research Charities take a role in 
issuing such guidance?
 Answer “who?  what?  where?  when?  why?  how?”
It is vital that a lay summary is well written, compelling, and 
demonstrates the significance of the research. It should answer 
the “so what?” question often uppermost in the minds of many 
reviewers, i.e. what makes this project exciting, relevant and 
worth doing now, above any of the others in their pile to review 
(or even above their own current research ideas)? Hence the 
lay summary can make a critical difference in how a proposal is 
reviewed and evaluated, but there is little agreement on how 
much space is available to get its message across. 
The UK Research Councils permit 4,000 characters in a grant 
application lay summary. By contrast research charities often 
use word limits that vary widely: the Stroke Association allows 
1,000 words but the British Heart Foundation merely 100.
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The National Institute for Health Research - Research for Patient 
Benefit scheme expects patients and carers to be represented in 
the design and management of studies [2].   A clear summary 
makes a project accessible by laypersons, becoming more 
involved in some funders’ peer review processes.
